Prematics(TM) Adds David J. Brailer, MD, PhD, to Board of Directors

BETHESDA, Md., Apr. 28 /PRNewswire/ -- Prematics today announced the close of Series B private equity financing led by Health Evolution Partners, an investment firm that seeks to identify and bring the "best of the best" in health care innovations to mainstream health practices. As part of the investment, David J. Brailer, MD, PhD, Chairman of Health Evolution Partners, will join the Prematics board of directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070315/CLTH096LOGO )

The financing also includes support from Prematics' founding investors, Foundation Capital and General Catalyst Partners. Both are top-tier venture capital firms with successful track records building world-class businesses. The investment will advance expanded deployment of Prematics' distinct medication management system, ScriptTone(SM), in partnership with health plans. ScriptTone supports physician acceptance of electronic prescribing through a no-cost, all-inclusive managed service model.

"This substantial commitment led by one of the nation's most respected leaders in health care technology demonstrates recognition for the effectiveness of Prematics' service-based deployment of clinical IT services," said Prematics president and Chief Executive Officer Kevin Hutchinson. "With support from Health Evolution Partners, Prematics is poised to leverage the strong momentum for electronic prescribing to improve health care delivery by improving safety, cost-effectiveness and overall quality."

David J. Brailer, MD, PhD, Chairman of Health Evolution Partners, will join the Prematics board of directors. Dr. Brailer was appointed by President Bush to be the first National Coordinator for Health Information Technology, overseeing the widespread deployment of health information technology from 2004 to 2006.

"The United States is well along in its transition to electronic prescribing," said Dr. Brailer. "Prematics brings a necessary and valuable solution to our payers, physicians and patients, and we have given them the resources they need to be the market leader in electronic prescribing."

In conjunction with the Series B financing, company co-founder and entrepreneur Scott Puritz will be stepping off the board of directors. "Scott has played a central role in Prematics' creation as its early driving force and former CEO," Hutchinson remarked. "We appreciate Scott's effort in positioning the company's early success and wish him well in his next new venture."

About Prematics

Prematics is an innovative provider of clinical information technology services committed to delivering solutions for physicians that improve the safety, quality and efficiency of health care. The company offers ScriptTone, the nation's first easy-to-use, fully managed electronic prescribing service designed for busy practicing physicians. This reliable and highly secure service is delivered over the company's proprietary end-to-end network and equips physicians with the critical patient information they need at the point-of-care to prescribe the most clinically appropriate and cost-effective medications. ScriptTone benefits all of the key industry stakeholders by driving patient safety, lowering costs, and streamlining fulfillment. More information about Prematics can be found at www.prematics.com.

About Health Evolution Partners

Health Evolution Partners is a health care investment manager founded in 2007. Health Evolution Partners invests across the health care industry, from early stage to buyouts and from services to technologies. It is seeking companies that can lead and become valuable in the new era of value-based, cost-effective and consumer-driven health care. To learn more about Health Evolution Partners, visit www.healthevolutionpartners.com.

    Media Contact
    Laura Rowe
    240-744-1217
    lrowe@prematics.com